At an Extraordinary General Meeting held today, Novartis shareholders approved the proposed 100% Spin-off of Sandoz, the Generics and Biosimilars business of Novartis. Shareholders also approved an ordinary capital decrease of the share capital of Novartis AG in the amount…
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), and North American Recue, a Henry Schein Medical business, today announced their presence at the EMS World Expo. From September 18 through September 22 in New Orleans,…
The “Florida Dialysis Centers Market Size, Share & Trends Analysis Report By Modality (In-Center, In-Home, SNF-based), By Dialysis Type (Hemodialysis, Peritoneal Dialysis), By Facility Type, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The Florida dialysis centers market size…
The “Ophthalmic Viscoelastic Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033“ report has been added to ResearchAndMarkets.com’s offering. This report provides a comprehensive analysis of the Ophthalmic Viscoelastic Devices (OVD)…
Emulate, Inc., the leading provider of next-generation in vitro models, today announced the publication “Integrating Liver-Chip Data into Pharmaceutical Decision-Making Processes” in Expert Opinion on Drug Discovery. The article introduces a decision-making framework that includes two guidelines for researchers to use in…
The “Cell Freezing Media Market Size, Share & Trends Analysis Report By Product (DMSO, Glycerol), By Application (Stem Cell Lines, Cancer Cell Lines), By End-use, By Region, And Segment Forecasts, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. This report projects that the global…
GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Ojjaara (momelotinib) for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis or secondary myelofibrosis (post-polycythemia vera and post-essential thrombocythemia), in adults with anemia. Ojjaara is a…
Nilogen Oncosystems, a privately-held biotechnology company dedicated to increasing efficiency and reducing risk in the oncology drug development process, has announced the appointment of its Vice President of Research and Operations, Rikhia Chakraborty, Ph.D., to Chief Scientific Officer. As Chief…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new analyses from studies of sotatercept, Merck’s novel investigational activin signaling inhibitor biologic, for adults with pulmonary arterial hypertension (PAH) (WHO Group 1) at the…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the European Commission (EC) has approved an expanded indication for ERVEBO for active immunization of individuals 1 year of age or older to protect…
CVS Health® Corporation (NYSE: CVS) today announced additional responsibilities for several members of the company’s executive leadership team, effective immediately: “At a time when we are accelerating our strategy to deliver superior health experiences for consumers, we are advancing leaders who…
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental Biologics License Application (COMIRNATY 2023-2024 Formulation) for individuals 12 years and older and granted emergency use authorization for individuals 6 months…